Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
0.726
-0.025 (-3.32%)
At close: Nov 20, 2024, 4:00 PM
0.704
-0.022 (-3.00%)
Pre-market: Nov 21, 2024, 7:24 AM EST
Outset Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 114.73 | 130.38 | 115.38 | 102.6 | 49.94 | 15.08 | Upgrade
|
| Revenue Growth (YoY) | -13.00% | 13.00% | 12.45% | 105.47% | 231.18% | 651.27% | Upgrade
|
| Cost of Revenue | 79.2 | 101.38 | 97.54 | 94.99 | 62.97 | 32.88 | Upgrade
|
| Gross Profit | 35.53 | 29 | 17.83 | 7.61 | -13.04 | -17.8 | Upgrade
|
| Selling, General & Admin | 121.36 | 141.46 | 130 | 101.39 | 75.58 | 29.18 | Upgrade
|
| Research & Development | 43.04 | 57.31 | 48.86 | 36.74 | 28.85 | 23.33 | Upgrade
|
| Operating Expenses | 164.4 | 198.77 | 178.85 | 138.13 | 104.43 | 52.51 | Upgrade
|
| Operating Income | -128.87 | -169.77 | -161.02 | -130.52 | -117.47 | -70.31 | Upgrade
|
| Interest Expense | -21.46 | -12.68 | -3.57 | -1.72 | -2.89 | -4.26 | Upgrade
|
| Interest & Investment Income | 10 | 10.17 | 3.29 | 0.5 | 0.53 | 2.49 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | -0.09 | 3.8 | Upgrade
|
| EBT Excluding Unusual Items | -140.33 | -172.27 | -161.29 | -131.74 | -119.93 | -68.28 | Upgrade
|
| Other Unusual Items | - | - | -1.37 | - | -1.57 | - | Upgrade
|
| Pretax Income | -140.33 | -172.27 | -162.66 | -131.74 | -121.49 | -68.28 | Upgrade
|
| Income Tax Expense | 0.61 | 0.52 | 0.3 | 0.2 | - | 0.02 | Upgrade
|
| Earnings From Continuing Operations | - | -172.8 | -162.96 | -131.94 | -121.49 | -68.3 | Upgrade
|
| Net Income | -140.94 | -172.8 | -162.96 | -131.94 | -121.49 | -68.3 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | -42.17 | 17.16 | Upgrade
|
| Net Income to Common | -140.94 | -172.8 | -162.96 | -131.94 | -79.32 | -85.46 | Upgrade
|
| Shares Outstanding (Basic) | 51 | 50 | 48 | 46 | 16 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 51 | 50 | 48 | 46 | 16 | 1 | Upgrade
|
| Shares Change (YoY) | 4.10% | 2.96% | 5.64% | 178.70% | 1806.53% | 18.34% | Upgrade
|
| EPS (Basic) | -2.75 | -3.48 | -3.38 | -2.89 | -4.85 | -99.60 | Upgrade
|
| EPS (Diluted) | -2.75 | -3.48 | -3.38 | -2.89 | -4.85 | -99.60 | Upgrade
|
| Free Cash Flow | -126.18 | -134.81 | -154.05 | -133.37 | -108.09 | -73.59 | Upgrade
|
| Free Cash Flow Per Share | -2.46 | -2.72 | -3.20 | -2.93 | -6.61 | -85.76 | Upgrade
|
| Gross Margin | 30.97% | 22.24% | 15.46% | 7.41% | -26.11% | -118.07% | Upgrade
|
| Operating Margin | -112.32% | -130.22% | -139.56% | -127.21% | -235.24% | -466.29% | Upgrade
|
| Profit Margin | -122.84% | -132.54% | -141.24% | -128.59% | -158.85% | -566.79% | Upgrade
|
| Free Cash Flow Margin | -109.98% | -103.40% | -133.52% | -129.99% | -216.47% | -488.03% | Upgrade
|
| EBITDA | -123.1 | -163.96 | -155.85 | -125.36 | -114.31 | -68.82 | Upgrade
|
| EBITDA Margin | -107.30% | -125.76% | -135.08% | -122.18% | -228.91% | - | Upgrade
|
| D&A For EBITDA | 5.77 | 5.81 | 5.17 | 5.16 | 3.16 | 1.48 | Upgrade
|
| EBIT | -128.87 | -169.77 | -161.02 | -130.52 | -117.47 | -70.31 | Upgrade
|
| EBIT Margin | -112.32% | -130.22% | -139.56% | -127.21% | -235.24% | - | Upgrade
|
| Revenue as Reported | 114.73 | 130.38 | 115.38 | 102.6 | 49.94 | 15.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.